Related references
Note: Only part of the references are listed.Farnesol increases the activity of echinocandins against Candida auris biofilms
Fruzsina Nagy et al.
MEDICAL MYCOLOGY (2020)
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
Belinda Ostrowsky et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast
Ryan Kean et al.
JOURNAL OF FUNGI (2020)
Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis
Adelaide Fernandes Costa et al.
MEDICAL MYCOLOGY (2019)
Effect of quorum sensing molecules and natamycin on biofilms of Candida tropicalis and other yeasts isolated from industrial juice filtration membranes
M. D. R. Agustin et al.
JOURNAL OF APPLIED MICROBIOLOGY (2019)
Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS
Mohammad H. Semreen et al.
MOLECULES (2019)
Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris
Catiana Dudiuk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Fungal Quorum-Sensing Molecules and Inhibitors with Potential Antifungal Activity: A Review
Arshad Mehmood et al.
MOLECULES (2019)
Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs
David Romera et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds
Arturo Casadevall et al.
MBIO (2019)
Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris
Ryan Kean et al.
MSPHERE (2019)
Candida auris outbreak: Mortality, interventions and cost of sustaining control
Surabhi K. Taori et al.
JOURNAL OF INFECTION (2019)
In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism
A. L. Bidaud et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Physiological and Transcriptional Responses of Candida parapsilosis to Exogenous Tyrosol
Agnes Jakab et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2019)
In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis
Renato Kovacs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Candida auris otomycosis in Iran and review of recent literature
Mahdi Abastabar et al.
MYCOSES (2019)
Potential Fifth Clade of Candida auris, Iran, 2018
Nancy A. Chow et al.
EMERGING INFECTIOUS DISEASES (2019)
Virulence Factors in Candida albicans and Streptococcus mutans Biofilms Mediated by Farnesol
Renan Aparecido Fernandes et al.
INDIAN JOURNAL OF MICROBIOLOGY (2018)
Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model
Hamed Fakhim et al.
MYCOSES (2018)
Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development
Gina Wall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A Candida auris Outbreak and Its Control in an Intensive Care Setting
David W. Eyre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?
Luana Rossato et al.
FRONTIERS IN MICROBIOLOGY (2018)
Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris
Alison M. Day et al.
MSPHERE (2018)
Candida auris: a Review of the Literature
Anna Jeffery-Smith et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017
Ana Belkin et al.
EMERGING INFECTIOUS DISEASES (2018)
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant FungusUnited States, May 2013-August 2016 (Reprinted from vol 65, pg 1234-1237, 2016)
S. Vallabhaneni et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart et al.
CLINICAL INFECTIOUS DISEASES (2017)
Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms
D. R. Monteiro et al.
JOURNAL OF APPLIED MICROBIOLOGY (2017)
Infection and tissue repair of experimental cutaneous candidiasis in diabetic mice
Andreia Carla Eugenio Pupim et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins
Andrew M. Borman et al.
MEDICAL MYCOLOGY (2017)
Killing Activity of Micafungin Against Candida albicans, C-dubliniensis and Candida africana in the Presence of Human Serum
Renato Kovacs et al.
MYCOPATHOLOGIA (2017)
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Liliana Scorzoni et al.
FRONTIERS IN MICROBIOLOGY (2017)
Current perspective on emergence, diagnosis and drug resistance in Candida auris
Smita Sarma et al.
INFECTION AND DRUG RESISTANCE (2017)
In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris
Hamed Fakhim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms
Renato Kovacs et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
Aliz Bozo et al.
JOURNAL OF MICROBIOLOGY (2016)
Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species
Andrew M. Borman et al.
MSPHERE (2016)
First hospital outbreak of the globally emerging Candida auris in a European hospital
Silke Schelenz et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2016)
Betamethasone augments the antifungal effect of menadionetowards a novel anti-Candida albicans combination therapy
Agnes Jakab et al.
JOURNAL OF BASIC MICROBIOLOGY (2015)
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms
Aspasia Katragkou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Killing rates exerted by caspofungin in 50% serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua
Renato Kovacs et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm
Li-hua Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Wee Gyo Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
D. Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Farnesol Induces Hydrogen Peroxide Resistance in Candida albicans Yeast by Inhibiting the Ras-Cyclic AMP Signaling Pathway
Aurelie Deveau et al.
EUKARYOTIC CELL (2010)
The quorum-sensing molecule E,E-farnesol - its variable secretion and its impact on the growth and metabolism of Candida species
K. Weber et al.
YEAST (2010)
Secretion of E,E-farnesol and biofilm formation in eight different Candida species
K. Weber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
Christopher G Pierce et al.
Nature Protocols (2008)
Protective effects of farnesol against oral candidiasis in mice
Tatsuya Hisajima et al.
MICROBIOLOGY AND IMMUNOLOGY (2008)
Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells
Mark A. Scheper et al.
NEOPLASIA (2008)
Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis
Amber Davis-Hanna et al.
MOLECULAR MICROBIOLOGY (2008)
Transcriptional response of Candida parapsilosis following exposure to farnesol
Tristan Rossignol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans
Dhammika H. M. L. P. Navarathna et al.
INFECTION AND IMMUNITY (2007)
Effect of farnesol on Candida dubliniensis morphogenesis
M. Henriques et al.
LETTERS IN APPLIED MICROBIOLOGY (2007)
Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance
Mary Ann Jabra-Rizk et al.
FEMS YEAST RESEARCH (2006)
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis
DHMLP Navarathna et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Farnesol and geranylgeraniol modulate the structural properties of phosphatidylethanolamine model membranes
SS Funari et al.
MOLECULAR MEMBRANE BIOLOGY (2005)
Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi:: comparison of different drug interaction models
J Meletiadis et al.
MEDICAL MYCOLOGY (2005)
Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains
AS Kantarcioglu et al.
MYCOSES (2002)
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol
JM Hornby et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2001)
Share Paper
